Comments*

 
  • Advances Against Aspergillosis II: Basic Science

    Edited by Karl V. Clemons (California Institute for Medical Research, San Jose, California), Malcolm Richardson (Wythenshawe Hospital, Manchester, UK), and David S. Perlin (New Jersey Medical School-UMDNJ, Newark, New Jersey)
    Volume 1273, December 2012
    11 Papers

    Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge—particularly in the face of increasing antifungal resistance. Bringing together the world’s leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary collaboration among clinicians, industry, and scientific experts, the “Advances Against Aspergillosis” conference was held January 26–28, 2012 in Istanbul, Turkey. Among the topics included are the evolution of modular conidiophore development in the aspergilli; diverse applications of RNA-seq for functional genomics studies in Aspergillus fumigatus; protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides; activation of the neutrophil NADPH oxidase by A. fumigatus; and cell biology of the innate immune response to A. fumigatus.

    Table of contents
    EmailPrint